Defense Secretary Pete Hegseth announced yet another deadly strike on a boat accused of ferrying drugs in the eastern Pacific ...

The Trump administration is nearing deals with drugmakers Eli Lilly and Novo Nordisk to offer some of their obesity drugs to ...

Despite no strong evidence of clinical benefit, microdosing GLP-1s will likely continue as a strategy for some to profit off of the popular drug class.

Panelists discuss how managed care organizations can leverage prescription digital therapeutics as cost-reduction tools to ...